The PE Ratio as of November 2024 (TTM) for BioRestorative Therapies, Inc. (BRTX) is -1.72

According to BioRestorative Therapies, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.72. This represents a change of -72.31% compared to the average of -6.21 of the last 4 quarters.

BioRestorative Therapies, Inc. (BRTX) Historical PE Ratio (quarterly & annually)

How has BRTX PE Ratio performed in the past?

The mean historical PE Ratio of BioRestorative Therapies, Inc. over the last ten years is -1.19. The current -1.72 PE Ratio has changed 14.40% with respect to the historical average. Over the past ten years (40 quarters), BRTX's PE Ratio was at its highest in in the December 2023 quarter at 1.75. The PE Ratio was at its lowest in in the September 2023 quarter at -24.55.

BioRestorative Therapies, Inc. (BRTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BioRestorative Therapies, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioRestorative Therapies, Inc. (BRTX) Average PE Ratio

How has BRTX PE Ratio performed in the past?

The current PE Ratio of BioRestorative Therapies, Inc. (BRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BioRestorative Therapies, Inc. (BRTX) PE Ratio vs. Peers

How is BRTX’s PE Ratio compared to its peers?

BioRestorative Therapies, Inc.’s PE Ratio is less than Pulmatrix, Inc. (-0.70), greater than Capricor Therapeutics, Inc. (-21.19), less than Akari Therapeutics, Plc (-1.14), less than Diffusion Pharmaceuticals Inc. (-0.00), greater than Soleno Therapeutics, Inc. (-33.16), less than Propanc Biopharma, Inc. (-0.06), greater than Cadrenal Therapeutics, Inc. Common Stock (-2.44), greater than Bonus BioGroup Ltd. (-3.01), less than InVivo Therapeutics Holdings Corp. (-0.11), less than Cingulate Inc. (-1.18), less than SAB Biotherapeutics, Inc. (-0.93), greater than Anebulo Pharmaceuticals, Inc. (-5.95), greater than Monopar Therapeutics Inc. (-8.34), greater than Can-Fite BioPharma Ltd. (-531.40), greater than Candel Therapeutics, Inc. (-3.10), greater than XTL Biopharmaceuticals Ltd. (-27.10), less than Cingulate Inc. (-1.18), greater than Achieve Life Sciences, Inc. (-5.91), less than Bio-Path Holdings, Inc. (-0.14), greater than Icosavax, Inc. (-8.27),

Build a custom stock screener for BioRestorative Therapies, Inc. (BRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioRestorative Therapies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioRestorative Therapies, Inc. (BRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioRestorative Therapies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.